Vir Biotechnology is now a two-engine company, with major pharma partnerships and a fully enrolled hepatitis delta phase 3 ...

Vir Biotechnology has appointed Aziz Sawaf as Executive Vice President and Chief Financial Officer, effective October 5, 2026 ...

(Nasdaq: VIR) today announced the appointment of Aziz Sawaf, MBEE, MBA, CFA, as Executive Vice President and Chief Financial ...

Nautilus Biotechnology Inc. stocks have been trading up by 15.14 percent amid heightened investor optimism from its latest ...

The latest update cuts the fair value price target for PDS Biotechnology from US$5.75 to US$4.75, signaling a more conservative valuation anchor for the stock. Analysts link this change to a mix of ...

Research and Markets has opened registration for the live online course, Protein Engineering for Pharmaceutical Biotechnology, organized by IPI Academy and taking place February 2-3, 2027, equipping ...

U.S. Rep. Scott Peters, along with Reps. Ro Khanna and Stephanie Bice and Sens. Todd Young and Maggie Hassan, introduced two ...

Devendra Fadnavis said Maharashtra will expand Marathi use in AI, quantum computing, space technology and biotechnology. The push aims to preserve the language's heritage while making it central to ...

The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a ...

Vir Biotechnology names Aziz Sawaf as EVP and CFO, with responsibility for finance, operations, IT, and investor relations.

ImmunityBio Inc. jumps as positive clinical trial progress drives bullish sentiment, with stocks have been trading up by 10.61 percent. Key Takeaways Market focus is on ImmunityBio’s ecosystem after ...